Olympus Corporation (OLYMY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Olympus Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Olympus Corporation (OLYMY) has returned -24.39% so far this year and -26.31% over the past 12 months.

Based on dividend-adjusted daily data since Jan 31, 2023, OLYMY's average daily return is -0.06%, while the average monthly return is -1.48%.

Historically, 45% of months were positive and 55% were negative. The best month was May 2024 with a return of +13.7%, while the worst month was Feb 2026 at -17.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, OLYMY closed higher 49% of trading days. The best single day was Nov 7, 2025 with a return of +8.4%, while the worst single day was Feb 13, 2026 at -11.7%.

Olympus Corporation has an annualized alpha of -22.10%, beta of 0.57, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since February 01, 2023.

• This stock participated in 208.36% of S&P 500 Index downside but only 22.81% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.57 may look defensive, but with R² of 0.07 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OLYMY ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Olympus Corporation (OLYMY) and compare them to a chosen benchmark (S&P 500 Index).

Olympus Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Olympus Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Olympus Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Olympus Corporation was 57.64%, occurring on Mar 13, 2026. The portfolio has not yet recovered.

The current Olympus Corporation drawdown is 49.84%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Olympus Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Olympus Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.